Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development

Author： Kushner Joseph  

Publisher： Informa Healthcare

ISSN： 1083-7450

Source： Pharmaceutical Development and Technology, Vol.18, Iss.2, 2013-04, pp. : 333-342

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IMPACT OF EXCIPIENT VARIABILITY ON DRUG PRODUCT PROCESSING AND PERFORMANCE

By  

Current Pharmaceutical Design, Vol. 21, Iss. 40, 2015-12 ,pp. : 5890-5899

Bentham Science Publishers

Access to resources Recommend Favorite

Statistical Analysis of Influenza Vaccine Lot Consistency Studies

By Nauta J.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 443-452

Taylor & Francis Ltd

Access to resources Recommend Favorite

Clinical-Pharmacological Strategies to Assess Drug Interaction Potential During Drug Development

By Kuhlmann J.   Mück W.  

Drug Safety, Vol. 24, Iss. 10, 2001-01 ,pp. : 715-725

Adis International

Access to resources Recommend Favorite

The Development of Hyaluronan as a Drug Transporter and Excipient for Chemotherapeutic Drugs

By  

Current Pharmaceutical Biotechnology, Vol. 9, Iss. 4, 2008-08 ,pp. : 253-260

Bentham Science Publishers

Access to resources Recommend Favorite

A Review of: "Excipient Development for Pharmaceutical, Biotechnology, and Drug Delivery Systems"

By Brittain Harry G.  

Pharmaceutical Development and Technology, Vol. 12, Iss. 1, 2007-01 ,pp. : 109-110

Informa Healthcare

Access to resources Recommend Favorite